Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 May;94(5):811-819.
doi: 10.1111/cen.14339. Epub 2021 Mar 14.

Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas

Collaborators, Affiliations
Multicenter Study

Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas

Joan Gil et al. Clin Endocrinol (Oxf). 2021 May.

Abstract

Objective: Large somatotrophic adenomas depict poor response to somatostatin receptor ligands (SRLs). Debulking has shown to enhance SRLs effect in some but not all cases and tumour volume reduction has been proposed as the main predictor of response. No biological studies have been performed so far in this matter. We aimed to identify molecular markers of response to SRLs after surgical debulking in GH-secreting adenomas.

Design: We performed a multicenter retrospective study.

Patients: 24 patients bearing large GH-producing tumours.

Measurements: Clinical data and SRLs response both before and after surgical debulking were collected, and 21 molecular biomarkers of SRLs response were studied in tumour samples by gene expression.

Results: From the 21 molecular markers studied, only two of them predicted enhanced SRLs response after surgery. Tumours with improved response to SRLs after surgical debulking showed lower levels of Ki-67 (MKI67, FC = 0.17 and P = .008) and higher levels of RAR-related orphan receptor C (RORC) (FC = 3.1 and P ˂ .001). When a cut-off of no detectable expression was used for Ki-67, the model provided a sensitivity of 100% and a specificity of 52.6% with an area under the curve of 65.8%. Using a cut-off of 2 units of relative expression of RORC, the prediction model showed 100% of sensitivity and specificity.

Conclusions: High levels of RORC and low levels of Ki-67 identify improved SRLs response after surgical debulking in large somatotropic adenomas. To determine their expression would facilitate medical treatment decision-making after surgery.

Keywords: RORC; Ki-67; acromegaly; somatostatin analogs; somatostatin receptor ligands; transsphenoidal surgery.

PubMed Disclaimer

References

REFERENCES

    1. Melmed S. Medical progress: acromegaly. N Engl J Med. 2006;355(24):2558-2573. https://doi.org/10.1056/NEJMra062453
    1. Petrossians P, Daly AF, Natchev E, et al. Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database. Endocr Relat Cancer. 2017;24(10):505-518. https://doi.org/10.1530/ERC-17-0253
    1. Kreitschmann-Andermahr I, Siegel S, Kleist B, et al. Diagnosis and management of acromegaly: the patient’s perspective. Pituitary. 2016;19(3):268-276. https://doi.org/10.1007/s11102-015-0702-1
    1. Colao A, Grasso LFS, Giustina A, et al. Acromegaly. Nat Rev Dis Prim. 2019;5(1):20. https://doi.org/10.1038/s41572-019-0071-6
    1. Melmed S, Bronstein MD, Chanson P, et al. A Consensus Statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol. 2018;14(9):552-561. https://doi.org/10.1038/s41574-018-0058-5

Publication types

LinkOut - more resources